January 29, 2007
Data Innovations Inc has announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for its flagship product, Instrument Manager, for use in blood banking environments.
The designation by the FDA will allow the company to market Instrument Manager v8.05 for use in blood banks and transfusion centers in the United States.
Instrument Manager is a comprehensive Middleware system that manages laboratory operations, including pre-analytical, analytical, and post-analytical sample processing and non clinical tasks such as equipment maintenance and specimen archiving.
For more information, visit the company’s Web site.
